Point72 Asset Management »

Verve Therapeutics shares owned by Point72 Asset Management

Quarter-by-quarter ownership of Verve Therapeutics (VERV) shares owned by Point72 Asset Management from 13F filings

Historical chart of Point72 Asset Management investment in Verve Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Verve Therapeutics held by Point72 Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Verve Therapeutics by Point72 Asset Management

Quarter filed Position value Share count Share price at filing
2023-06-30 $61k 3.3k 18.75
2023-03-31 $1.8k 124 14.42

More positions owned by Point72 Asset Management

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Amazon (AMZN)
Meta Platforms Cl A (META)
Dell Technologies CL C (DELL)
Union Pacific Corporation (UNP)
Boston Scientific Corporation (BSX)
Johnson Ctls Intl SHS (JCI)
NVIDIA Corporation (NVDA)
FedEx Corporation (FDX)
Microsoft Corporation (MSFT)
CSX Corporation (CSX)
Honeywell International (HON)
Thermo Fisher Scientific (TMO)
Oracle Corporation (ORCL)
Western Digital (WDC)

View all positions for Point72 Asset Management

Top funds holding Verve Therapeutics

Alphabet
ARK Investment Management
Vanguard Group
Federated Investors
Casdin Capital
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas
Jpmorgan Chase & Co
Arch Venture Corp
Redmile Group
Baker Bros. Advisors
EcoR1 Capital
BVF
Palo Alto Investors
Citadel Advisors

View all funds holding Verve Therapeutics